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Metridium senile, Halocynthia pyriformis and ParaParastichopus tremulus were subjected to 
organic and aqueous extraction. The aqueous extract was made with water, while the organic was 
made with dichloromethane and methanol in 1:1 ratio. The aqueous and organic extracts were 
fractionated on reversed-phase HPLC and tested for antiviral activity against Herpes simplex 
virus-1. All the three organisms displayed anti-viral activity in the primary screening, but when 
retested their activity were lost. During the work with the thesis Dendrodoa aggregata was 
included.Screening of D.aggregata had shown that deoxytubastrine had antiviral activity in pilot 
studies. Tubasterine has shown antiviral activity in earlier studies so it was decided to purify and 
test deoxytubastrine against HSV-1. Analysis on LC-MS ESI-TOF in positive mode indicated the 
active compound with m/z 178.0906 amu which gave us the elemental composition C9H11N30. 
The identity of deoxytubastrine was confirmed by LC-MS ESI-TOF in positive mode and 1H-

















ACN  Acetonitrile 
DCM  Dichloromethane 
D-MEM Dulbeccos Modified Eagles medium 
DMSO  Dimethyl sulfoxide 
ESI  Electrospray ionization 
FBS  Fetal veal serum 
HPLC  High performance liquid chromatography 
m/z  mass to charge ratio 
MeOH  Methanol 
MS  Mass spectrometry 
MTT  2H-Tetrazolium,2(4,5-dimethyl-2-tiazolyl)-3,5-diphenyl-,bromide 
M09036 Metridium senile 
M09037 Parastichopus tremulus 
M09038 Halocynthia pyriformis 
PBS  Phosphate buffered saline 
RPMI  Rosell Park Memorial Institute medium 
TOF  Time of flight 













Humans have always been dependent of natures resources to obtain clothes, shelter and 
medicines. Chemical substances derived from animal, plants and microbes have been used for 
treating human diseases since the beginning of medicines history [1]. It is estimated that 60 % of 
the medicines people can get prescribed today can be traced back to nature [2]. However almost 
all of these drugs have arisen from terrestrial organisms, even though life in the sea has evolved 
with a very interesting and highly complex chemistry. Life in the sea appear in the strangest 
places and have produced the weirdest organisms and might have very big potential for treating 
human diseases [2]. The main reason there is less medicines arising from marine organisms has 
been the possibility to access the ocean depths and securing a reliable supply. 
Marine organisms live under totally different environments than terrestrial. This makes life in the 
ocean unique and there are possibilities to find animals, plants and microbes very different than 
on land. The chemicals they make are very interesting for pharmaceuticals, since the possibility 
of finding lead-compounds never found before is high.  
Marine bioprospecting is searching the ocean depths for these marine organisms and investigate 
whether they have any interesting molecules or genes which can be beneficial for humans. Since 
there has been little focus on the oceans as mentioned before, and that approximately 70 % of 
earths surface consists of water, the chances of finding novel interesting molecules or genes are 
very high. Especially when it comes to the areas along the Norwegian coast and the Barents Sea 
where there has been minimal exploration of the marine fauna for this purpose. Organisms living 
in cold environments develop different molecules than organisms living in warm. This is because 
it takes different characteristics and biochemical processes to live under extreme conditions such 
as low temperature, low pressure and little sunlight. Organisms living under these circumstances 





1.2 MabCent SFI 
MabCent –SFI is a Research based innovation centre which was started up in March 2007. It was 
established by the Research council of Norway and is hosted by the University of Tromsø. 
 Their field of research is through marine bioprospecting to analyze and characterize the bioactive 
compounds from Arctic and sub-Arctic marine organisms that have the potential for further 
research and commercialization.  
Together with Marbio, which is were the high- throughput screening for bioactive compounds is 
performed, they purify, screen and identify compounds within several areas. The main focus is 





The phylum Cnidaria includes the classes Scyphozoa, Cubozoa, Hydrozoa and Anthozoa. They 
are characterized by their radial or biradial symmetry. The basic structure is sac-like with the 
mouth as a single terminal opening, which also function as an anus. The mouth is surrounded by 
circles of tentacles. They only have two layers of cells in the body wall, ectoderm and endoderm, 
between which is the mesoglea. The mesoglea forms a thick fibrous layer in anemones. All 
cnidarians are characterized specially by the presence of stinging capsules on the tentacles of 
various types which are unique to the phylum. The cnidarians have two basic structures by which 
they are recognized from, a polyp (M.senile) which is sessile, more or less cylindrical and has the 
mouth at the free distal end. A medusa is free swimming, bell- to saucer shaped, with the surface 
upward and the tentacles and mouth on the abdominal side. The polyps may propagate asexually 
by fission or budding new polyps from themselves[4]. 
 
1.3.1.1 Metridium Senile 
Metridium senile(sea anemone) belongs to the class Anthozoa from the phylum Cnidaria. They 
are very common from Scandinavia to Biscay. They can be found across the beach zone, 
overhangs, caves, beneath boulders on the lower shore and further down to 100 meters depth. 
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M.senile has a characteristic appearance with many, short tentacles which gives the anemone a 
soft expression. It can be as tall as 500 mm and are among the biggest sea anemones [4, 5].  
 
 
Figure 1: Picture of M.senile. Published with permission from Sten-R Birkely, Marbank. 
 
Despite the lack of efficient physical protection in a hostile environment, the Anthozoans survive 
mainly because of their chemical defense system by a series of secondary metabolites 
accumulating in their body or releasing to their surroundings. Some of the chemicals previously 
isolated from them are 5 cembrene-type diterpenes[6]. For example flexibilide, dihydroflexibilide, 
sinulariolide, epi-sinulariolide and epi-sinulariolide acetate from the coral S.flexibilis has showed 
remarkable antimicrobial activity, and have especially inhibited the growth of Gram-positive 
bacteria, such as S.aureus. Another substance, Briarellin Q, from the octocoral B.polyanthes has 
showed significant antiplasmodial activity in vitro against chloroquine-resistant Plasmodium 
falciparum, in addition it has showed strong activity against Mycobacterium tuberculosis[6]. 
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Figure 1: Diterpenes from Sinularia flexibilis 
 
Metridoiolysin, a cytolytic and lethal protein from M.senile has been isolated[7]. It has been 
shown that metridiolysin possesses some distinctive properties in common with streptolysin O 
and other SH-activated cytolysins of bacterial origin. For example the lytic abilities for platelets 
and other mammalian cells[7].  
In addition to M.senile this thesis included antiviral screening from H.pyriformis and P.tremulus. 
These were purified in two other parallel projects. Another marine organism D.aggregata was 
also included during the work with this thesis; this organism had been purified at MabCent earlier. 
1.3.2 Chordata 
The phylum Chordata includes the class Asidiacea. They separate from every other animal in four 
basic ways in which they are built up. That is their central nervous system placed on the animals 
back like a tube shaped string which goes over to their spinal marrow. Under the neural tube lies 
the embryos chorda dorsalis. Beneath the chorda dorsalis you can find the intestinal tract, with its 
frontal part designed as respiratorytract. Their heart lies on the abdominal side[8]. 
1.3.2.1 Halocynthia pyriformis 
Halocynthia pyriformis belongs to the class Ascidiacea from the phylum Chordata. Although 
they have been observed as far south as Stavanger, they are especially common in northern 
Norway. They can be as tall as 100 mm. They normally live in low water and are usually red 
colored, but some examples in white has also been seen. H.pyriformis can be found both in areas 
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with strong streams and areas whit stagnant water and in any substrate from the tidal zone and 











Figure 2: Picture of H.pyriformis. Published with permission from Sten-R Birkely, Marbank. 
 
1.3.2.2 Dendrodoa aggregata 
Dendrodoa aggregata also belongs to the class Ascidiacea from the phylum Chordata. It is very 
common in the northern parts of Norway. The specie lives both in colonies and separately. They 
are characterized by a spherical sack like shape, with two short siphons. 
They can usually be found under rocks, empty sea shells and other shellfish. You can find them 










Figure 3: Picture of D.aggregata. Published with permission from Robert A. Johansen, Marbank. 
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1.3.3 Echinodermata 
The phylum Echinodermata includes the classes Crinoidea, Asteroidea, Ophiuuroidea and 
Echinoidea. The phylum has a distinctive radial pattern which may take the form of five arms 
radiating from a central disc or a more globular or cylindrical shape. The typical echinoderm has 
an outer lay of calcareous skeletal plate. These may be joined together to form a complete shell. 
The echinoderms have a unique hydraulic water vascular system which controls the action of the 
tube feet. It consists of a ring around their throat and a radiating vessel internal to each 
ambulacrum. Echinoderms can live in a diversity of habitats. They are fully marine and barely 
penetrate estuaries. They can avoid desiccation by confining to rock pools and under boulders[4]. 
1.3.3.1 Parastichopus tremulus 
Parastichopus tremulus belongs to the phylum Echinodermata. The specie has it habitat from 
northern Norway to Biscay. It is a big sea cucumber and can get as big as 50 cm long. They have 
a beautiful red colored back and are white on the abdominal side. Their body is covered with 
papillae which make it look like a wart. The tentacles around their mouth are very short. They are 
very common in the fjords from 20-1200 meters depth[5]. 
 
Figure 4: Picture of P.tremulus. Published with permission from Robert A. Johansen, Marbank. 
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1.4 Reversed phase HPLC 
High Performance Liquid Chromatography is the most widely used method in analyzing 
pharmaceuticals. The method is based on having a sample injected in a mobile phase that is 
pumped through a column packed with materials that will retard and by that separate the 
molecules in the sample before they are detected by a detector. The pumps must be able to pump 
the mobile phase in a constant velocity against high pressure. The particles in the column give a 
counter pressure of 30-300 bar when the mobile phase is pumped through.   
The column used in the HPLC in this thesis is reversed phase columns where the stationary phase 
is hydrophobic and the mobile phase aqueous solutions with acetonitrile and formic acid as 
organic modifiers. The sorbent in the columns are made by attaching hydrophobic groups, here 
C18-material, to silanol groups[9]. 
 
1.5 LC-MS 
Mass spectrometry (MS) is a method that is based on the production of ions from molecules, 
which then are separated according to their mass-to-charge (m/z) ratio and detected in a detector. 
There are many different ion sources and mass separators, but in this thesis it will be focused on 
MS with electrospray ionization, triple quadrupole mass separator and time-of-flight mass 
separator[10]. 
In many applications that are measured with mass spectrometry, the sample that is to be analyzed 
is dissolved, preferably in an aqueous phase. The solution must flow into the front of the MS, but 
before it can provide a spectrum the solvent must be removed without loosing the sample.  If this 
is not removed, its vaporization when entering the vacuum of the MS will produce a large 
increase in pressure and stop the instrument from working properly. Electrospray ionization is 
one of several ways of effecting the differentiation between the carrier solvent and the sample of 
interest. But unlike other methods introducing liquid into a MS, in addition of making ions a 
single charge electrospray also produces multiply charged ions that make accurate measurements 
of larger masses easier.[11]  
Electrospray ionization takes place under atmospheric pressure making pseudo-molecular ions, 
these species are non-covalent complexes formed between an analyte of interest and any other 
components present in the ionized sample. The solution is pressed through a stainless capillary 
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and when applying a high voltage on the capillary, an aerosol is formed. This aerosol formation is 
assisted by using a nebulizer gas, often nitrogen, which flows around the capillary. The gas will 
also evaporate the charged droplets, which results in ionic species in the gas phase. These species 
are either positively or negatively charged depending on the potential applied to the capillary. 
This means that when a positive potential is applied, only positive charged species are made. 
Depending on what the solution has present, several species other than [M+H]+ can be formed. 
These are often Na+, K+ and NH4+. Likewise when a negative potential is applied, only negative 
charged species are made. Also here other species than [M-H]-  can be made depending on other 




Figure 5: Schematic drawing of a Trippel quadrupole. Published with permission from Terje Vasskog. 
 
The triple quadrupole (QqQ) has two quadrupoles with a hexapole or octapole in between. The 
quadrupole is made out of four parallel rods, where the pairs opposing each other are connected 
electrically. In the triple quadrupole Q1 and Q2 are the mass analyzers in which the ions are 
separated based on their m/z-ratio. The third quadrupole,which actually is a hexapole or octapole, 
is a collision cell. An radio frequency voltage is applied on the rods of the collision cell guiding 
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the ions through the cell without separating them. When an inert gas such as Ar, He or N2 is 
introduced the collisions will be induced between the collision gas and the analyte ions.  
If the collisions have high enough energy, the internal energy of the ions will increase and they 
can be fragmented and introduced to Q2 and separated. 
The mass spectrometer can be used as both a specific and a general detector. When used as a 
general detector the radio frequency voltage and direct current voltage are varied to scan the 
desired m/z interval. 
As a specific detector the radio frequency voltage and direct current voltage is set with specific 
values so only ions with specific m/z gets through the quadrupole in a specific time interval [12]. 
 
 
Figure 6: Schematic drawing of ESI-TOF MS with double reflectors. (www.waters.com) 
 
The concept of Time of flight mass spectrometry (TOF) is that for a given population of ions 
which are all accelerated to the same kinetic energy, the ions which have a lower mass will have 
greater velocity when travelling and reach an end point sooner. Each ion with a particular m/z 
ratio has a unique flight time. The flight time begins when a high voltage pulse is applied to the 
back plate of the ion pulser and ends when the ion strikes the detector at a known distance[13]. 
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One of the disadvantages of TOF is their restricted dynamic area, caused by the detectors need of 
time between every time it measures the ions (~ 5ns). If the sample is too concentrated, the 
detector will not manage to reset between each measurement since there is too many ions 
reaching the detector at the same time. 
One of TOFs great advantages is that it calculates the molecule weight with great accuracy 
(below 5 ppm uncertainty). This is achieved by introducing a reference compound along with the 
sample. Since the ion source has two probes, one analyze probe and one reference probe, every 
15 seconds there will be made a reference specter that is used to adjust the analyte spectra[14].  
The instrument has almost an unlimited mass range, high analyzing speed and high resolution. 
Reflectors are used to balance the fact that the ions can have different kinetic energy. The ions 
with high kinetic energy will penetrate deeper in the reflector and use longer time before they 
turn than the ions with low kinetic energy. Several reflectors after each other will make the 
resolution even better.   
 
1.6 Extraction 
During the extraction the aim is to extract the compounds from the freeze-dried material over to 
the solution the extraction is made with. Since the theory says that like dissolves like the 
extraction is made in two stages. First the freeze-dried material was extracted with water in order 
to extract the polar molecules over to the aqueous phase. Then the apolar compounds that were 
left in the material were extracted with DCM and methanol. One can also upgrade the extraction 
by adjusting for example the pH in order to increase the selectivity of the extraction. 
Since it is not know what kind of compounds the organism consist of, the best is to make an 
extraction that is as general as possible. 
 
1.7 Virus 
Viruses differ from all other infectious organisms in their structure and biology, especially in 
their reproduction. Although they carry conventional genetic information in their DNA or RNA, 
they do not have synthetic machinery that is needed for this information to be used to make new 
virus material. Virus itself is metabolically inert, and can only replicate after infecting a host cell 
and parasitize the hosts ability to transcribe or translate genetic information. They cause some of 
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the most common and some of the most deadly diseases in humans, exemplified with influenza 
and Ebola virus [15]. 
In this thesis Herpes simplex virus 1 (HSV-1) was used under the antiviral screening. Herpes 
simplex virus is a medium sized double-stranded DNA virus. There are actually two types of 
herpes simplex virus, HSV-1 and HSV-2. They cause a variety of clinical symptoms, with the 
basic lesion being an intraepithelial vesicle where the virus is shed. The infection usually 
transmits from the saliva or cold sores of other individuals. HSV-2 arose as a sexually transmitted 
variant of HSV-1, but lately the sites infected by the two types are less clearly distinct.  
HSV is called a virulent virus and their lytic cycle is a six stage cycle. It starts at the penetration 
of the host cell. The viral acids will then form a circle, making the cell mistakenly copy viral 
DNA as its own. The viral DNA will then organize them selves as virus. Virus particles will then 
bud the cells and the viruses are free to infect other cells.  
There is today over 40 compounds that are commercially available in pharmaceutical markets 
including alternative antiviral medicines [16]. Compounds extracted from algae have shown 
activity against a wide range of viruses, including HSV-1, HSV-2, HIV and others. Another 
compound, Fucoidan which is a sulfated polysaccharide isolated from Fucus vesiculosus, has 
shown inhibitory effect on the replication of DNA viruses. 
But the most important contribution of marine organisms to antiviral medicines was the isolation 
and characterization of arabinosyl nucleosides from the sea sponge Thethya cripta. Semi 
synthetic modifications of arabinosyl nucleosides have resulted in producing  cytarabine, 
acyclovir and azidothymidine which are in clinical use today [16]. 
 
1.8 Description of methods 
The methods used in this thesis have all been taken from the methods that are used in Marbio 
which has established methods from sample preparation to fractionation and screening. The 
methods are designed is such manner that they can pick up as many compounds as possible, from 
small organic molecules to big macromolecules. 
First all the organisms were cut to small pieces and freeze-dried. Sample materials were extracted 
in water and then a mixture of dichloromethane and methanol. These extractions are a simple 
way to separate the polar and apolar molecules from each other. 
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The organic and aqueous extracts where then fractionated by high performance liquid 
chromatography (HPLC). The fractions from the HPLC were tested for antiviral effects on HSV-
1. 
The antiviral screening is based on plaque- reduction assay (PRA-assay). The PRA-method 
measures viral efficiency in forming plaques in the presence of antiviral compounds.  The cells 
are exposed with virus and a HPLC-fraction to see how many plaques is produced. 
Immonuglobuline (IgG) is also added to the media to prevent viruses to infect other cells when 
budding out. In this way only the cells that are infected the first time will produce plaques. 
Number of plaques formed in the wells that have been infected with HSV-1, is compared to the 
number of plaques formedin the wells that in addition has been exposed to test compounds. The 
cell line that is used for the antiviral screening is the African Green Monkey kidney cells (Vero 
cells). 
Some active fractions were also tested with 2H-Tetrazolium,2-(4.5-dimethyl-2-3,-5 diphenyl-
,bromide) assay (MTT). The MTT- method measure the toxicity of fractions against the test cells 
(Vero cells). 
Fractions that show activity are further tested in different dilutions and screened again to confirm 
the activity. The fractions still having activity after the second screening will be purified and 
analyzed with mass spectrometer (MS). By using MS one can try to determine the exact mass and 
element composition of the active components. When element compositions are found they can 
be compared in different databases to find out if they are molecules previously discovered. This 










The aim of this thesis is to try to find compounds with antiviral activity in M.senile, H.pyriformis, 
P.tremulus and D.aggregata. Two different extractions will be made, the first with water and the 
other a mixture of dichloromethane and methanol in 1:1 ratio, in order to find out if this has any 
effect on the screening result. Finally we will try to identify the known compounds by searching 


















2. Materials and methods 
2.1 Sampling and storage 
Materials: 
Heto Powerdry PL9000    Thermo (Waltman,USA) 
Scale      Mettler Toledo (Greifensee, Switserland) 
IKA A11 Basic     IKA Works (Staufen,Germany) 
 
Metridium senile was collected 30th of May 2009 in Porsangerfjorden, Finnmark with Agazziz 
trawl at 62 meters depth.  
ParaParastichopus tremulus was collected 6th of March 2009 in Tysfjorden with Agazziz trawl at 
378 meters depth. 
Halocynthia pyriformis was collected 29th of May 2009 in Porsangerfjorden, Finnmark by diving 
at 20 meters depth.  
Dendrodoa aggregata was collected 5th of December 2006 in Skattøra, Tromsø at 35 meters 
depth. The organisms were then stored at -20oC. 
Frozen organisms were later taken out of the freezer, weighed and transferred to a wooden board. 
The frozen material was cut in 1 cm3 pieces and transferred to a bowl. Aluminum foil with holes 
were used as cover and the bowls were then placed in Heto Power Dry PL 9000 for freezedrying. 
2.2 Aqueous extract 
Materials 
Rotary evaporator, Laborata 4002   Heidolph (Nürnberg,Germany) 
Heto Powerdry PL9000    Thermo  
Scale       Mettler Toledo  
Centrifuge      Multifuge 3 S-R (Heraeus) 
Milli-Q water      Millipore (Billerica, MA, USA) 
Ethanol      Merck (Darmstadt,Germany) 
22 μm Millex GS filter    Millipore  
Universal SM 30   Edmund Bühler GmBH (Hechingen,Germany) 
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The freeze-dried Metridium senile M09036-0-W01(153.54 g) was transferred to a mill and 
pulverized. The pulverized material was transferred in small doses to a Duran bottle by a funnel 
and Milli-Q water was poured in the bottle. Approximately 200 mL Milli-Q water was added at 
each addition of pulverized material and shaken until the amount of Milli-Q water corresponded 
to approximately 10x the weight of the material or got the consistency of a “soup”. It was totally 
added 1.1 L Milli-Q water. The suspension was then stored at 5 oC in the refrigerator until the 
next day.  
The suspension was centrifuged the next day for 30 min at 4000 rpm and 5oC. The supernatant 
was decanted into 1 L flasks, and it was made sure that the fatty layer did not enter the flasks. 
Milli-Q water was added to the pellet, mixed properly and placed in the refrigerator for 30 min, 
before the process of centrifuging and decanting was repeated and the 2 supernatants were pooled. 
The supernatant was distributed to flasks (approximately 400 mL per flask) and placed in the 
freezer at a tilting angle and rotated every 20 min to ensure even distribution in the bottle. This is 
to make the freeze- drying easier and more efficient. The flasks were then placed in Heto Power 
Dry PL 9000 for freezedrying. The material was pulverized, scraped out and transferred to a bowl 
before it was stored at -20 °C. 
It was weighed out 213 mg of the extract to a centrifugation tube and added 2 mL Milli-Q water. 
The mixture was shaken for 90 minutes, before 1 mL of it was transferred to another 
centrifugation tube. It was added 4 mL 96 % EtOH to the tubes and shaken well on a Universal 
SM 30 minishaker before being placed in the freezer over night. The next day the mixtures were 
thawed and then shaken vigorously and centrifuged at 4000 rpm for 30 min. The supernatant was 
transferred to a 25 ml rotary evaporation flask and vacuum evaporated at 40 oC down to 
approximately 2 mL. The mixture was placed in the freeze. The next day 2 mL of the mixture 
volume was divided to two centrifugation tubes containing 1 mL each and centrifuged at 13000 
rpm for 30 min. The supernatant was filtered through 0.22 μm Millex GS filter over to HPLC 





2.3 Fractionation of aqueous extract 
Materials 
Waters 600 Controller     Waters (Milford,USA) 
Waters 2996 Photodiode Array Detector   Waters  
Waters 2767 Sample Manager    Waters  
Atlantis Prep C-18 (10x250 mm; 10μm)   Waters  
Acetinitrile       Merck  
Milli-Q water       Millipore 
Formic acid 
Waters 600E Multisolvent delivery System   Waters  
Waters Prep Degasser      Waters  
Waters 2767 Sample Manager, Injector and Collector 
Waters 2996 PDA Detector 
SpeedVac  
 
The aqueous extract from Metridium senile (M09036-0-L01) was now ready to be fractionated. 
From each tube 1000 µL of sample was injected in the HPLC column and fractionated with a 
flow rate of 6 mL/minutes and the eluent was collected over a time span of 40 minutes, resulting 
in 40 fractions. The gradient used in the process is shown in table 1. Each of the 40 fractions were 
distributed between 4 deep well plates and vacuum centrifuged for 1 hour and placed in the Heto 
Powerdry PL9000 for freeze drying. 
 











Table 1: Mobile phase gradient for the fractionation of aqueous extracts. 
Time (min) Flow (ml/min) Moblie phase  
A % w/ H2O 
and 0.1 % 
formic acid 
Moblie phase  
B % w/ ACN 
and 0.1 % 
formic acid 
Curve 
         0         6        95        5         0 
         3         6        95        5         6 
        30         6       50        50         6 
        35         6       5        95         6 
        40         6       5        95         6 
        41         6       95        5         6 
 
2.4 Organic extract 
Materials 
Rotary evaporator, Laborata 4002   Heidolph 
Heto Powerdry PL9000    Thermo 
 Scale       Mettler Toledo 
Centrifuge      Multifuge 3 S-R 
Milli-Q water      Millipore 
Whatman no 3 filter     Whatman (Maidstone, England) 
Dichloromethane     Merck  
Methanol      Merck  
Universal SM 30     Edmund Bühler GmBH  
 
The dry pellet remaining after the aqueous extract (75.42g) and stored in the freezer was freeze-
dried and pulverized in a mill and transferred to a Duran bottle. A mixture of DCM and MeOH 
(1:1) was added to the pulverized material until it corresponded to  
Approximately 10x the weight of the pellet and got a “soup” like consistency. The suspension 
was shaken vigorously and stored in the refrigerator until the next day. The suspension was 
vacuum filtrated the next day with Whatman nr 3 filter. When the suspension was filtrated, the 
pellet was reextracted in DCM/MeOH for 30 min and filtrated. 
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The pooled filtrate was transferred to a rotary evaporation flask and vacuum evaporated at 40 oC 
until there was 10-20 mL left. The concentrated filtrate was transferred to HPLC tubes and stored 
at -20 oC. 
The organic extract was taken out from the freezer and 241.5 mg was transferred to one tube and 
258.8 mg to another. It was added 3 mL hexane to each tube and shaken vigorously on a 
minishaker. Then 3 mL 90 % ACN was added to both and shaken vigorously on a minishaker.  
The mixtures were centrifuged for 3 min at 3000 rpm before the ACN phase was transferred to a 
evaporation flask 
3 mL 90 % ACN was added to the hexane phase again in both tubes and centrifuged, before the 
ACN phase was transferred to an evaporation flask. 
The flask with the ACN phase was vacuum evaporated until there was approximately 2 mL left. 
The volume was distributed to two centrifugation tubes and the volume was adjusted to 1 mL 
with 90 % ACN before being placed in the freezer to the day after. The next day the 2 
centrifugation tubes were thawed and shaken on a minishaker and centrifuged at 13000 rpm for 
30 minutes. The mixture was transferred to 2 HPLC tubes and the volume was adjusted to 1 mL 
in each tube and it was ready for fractionation. 
 
2.5 Fractionation of organic extract 
Materials 
Waters 600 Controller     Waters  
Waters 2996 Photodiode Array Detector   Waters  
Waters 2767 Sample Manager    Waters  
XTerra® Prep RP18 (10x300 mm; 10μm)   Waters  
Acetinitrile        Merck  
Milli-Q water       Millipore 
Formic acid       Merck 
Waters 600E Multisolvent delivery System   Waters  
Waters Prep Degasser      Waters  
Waters 2767 Sample Manager, Injector and Collector Waters 
Waters 2996 PDA Detector     Waters 
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SpeedVac        
The organic extracts were now ready to be fractionated. From each tube 1000 µL of sample was 
injected in the HPLC column and fractionated with a flow rate of 6 mL/minutes and the eluent 
was collected over a time span of 40 minutes, resulting in 40 fractions. The gradient used in the 
process can be seen in table 2. Each of the 40 fractions were then distributed between 4 deep well 
trays and vacuum centrifuged for 1 hour and placed in the Heto Powerdry PL9000 for freeze 
drying. 
The other organisms included in this thesis have undergone the same procedure for the organic 
extract. 
 
Table 2: mobile phase gradient for fractionation of organic extracts. 
Time (min) Flow (mL/min) Mobile phase A 
% w/H2O and 
0.1 % formic 
acid 
Mobile phase B 
% w/ ACN and 
0.1 % formic 
acid 
Curve 
            0             6          80           20           0 
            2             6          80           20           6 
           30             6           0           100           6 
           40             6           0           100           6 
           41             6          80           20           6 
 
2.6 Dissolving HPLC-fractions 
The organic HPLC-fractions in the deep well trays were added 7.5 μL DMSO and was shaken for 
2.5 hours. Afterwards 750 μL D-MEM without FBS were added and the trays were shaken for 
another 30 minutes, before another 750 μL D-MEM without FBS were added and shaken for 5-6 
minutes. 
 
The aqueous HPLC-fractions in the trays were added 750 μL D-MEM without FBS and shaken 
for 2.5 hours. Afterwards another 750 μL D-MEM without FBS were added and the shaking 
procedure repeated for 30 minutes.  
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2.7 Plaque Reduction Assay 
Materials and chemicals: 
D-MEM      Invitrogen (Carlsbad, USA)  
FBS, Fetal veal serum     Biochrom (Cambridge, UK) 
Gammaglobuline 7 mg/mL    Sigma Aldrich (Munchen,Germany) 
Crystal violet      Sigma Aldrich  
Methanol      Merck 
Milli-Q water      Millipore 
Incubator, 37o, 5 % CO2    Samyo Electric 
 
Virus: 
HSV-1, ATCC VR-539 
Cell line: 
African Green Monkey kidney cells (Vero cells)  ATCC no: CCL-81TM  
 
Day 1: 
Vero cells were split up and cultivated in 24 well plates with a cell density of 1*105 cells/well in 
1 mL medium and incubated over night at 5% CO2, 37oC.  
Day 2: 
The next day a virus dilution giving 500 plaque forming units/mL was made in D-MEM 
w/FBS.The medium in each well were removed. It was added 100 μL HPLC- fractions and 100 
μL virus solution to each well. The positive control was set to 100 μL virus solution and 100 μL 
D-MEM without FBS. The negative control was set to 100 μL D-MEM with FBS and 100 μL D-
MEM without FBS. 
The cells were then incubated for one hour at 37oC, 5 % CO2 to adsorb virus to the cells.  
After one hour the medium in each well were removed and the cells were washed one time with 
PBS. 150 μL HPLC-fraction and 150 μL IgG solution were then added to each well and the cells 
were incubated for 48 hours at 37oC, 5 % CO2. 
Day 4: 
After 48 hours the medium in each well were removed and crystal violet in 5% methanol was 
added to each well and incubated for 20 minutes. Then the crystal violet was removed and the 
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fixed cells were washed carefully with Milli-Q water 3 times, before the wells were dried so the 
number of plaques could be counted under a loupe. 
 
Table 3: HPLC fractions in plaque reduction assay. V= virus control/positive control, C= cell control/negative control 
1 2 3 4 5 6 
1 2 3 4 5 6 
7 8 9 10 v C 
7 8 9 10 v C 
 
11 12 13 14 15 16 
11 12 13 14 15 16 
17 18 19 20 v C 
17 18 19 20 v C 
 
21 22 23 24 25 26 
21 22 23 24 25 26 
27 28 29 30 v C 
27 28 29 30 v C 
 
31 32 33 34 35 36 
31 32 33 34 35 36 
37 38 39 40 v C 

















2.8 MTT assay 
Materials and chemicals: 
DMSO         Sigma Aldrich 
RPMI-1640      Biochrom 
D-MEM      Invitrogen 
Aqueous One Solution Reagent (AQOS)  Promega 
FBS, Fetal veal serum     Biochrom 
DTM 880 Multimode Detector   Beckman Coulter  
Plate station-SAGIAN    Beckman Coulter 
Multimode detection software   Beckman Coulter 
Micro titer tray     Nunc 
Incubator, 37o, 5 % CO2    Samyo Electric 




African Green Monkey kidney cells (Vero cells) ATCC no: CCL-81TM 
 
Day 1: 
Vero cells were split up and cultivated in 96 well plates with a cell density of 1 x 104 cells/well 
medium and incubated over night at 5% CO2, 37oC. 
Day 2: 
The medium in each well were removed. It was added 50 μL RPMI-1640 with 10 % FBS and 50 
μL of purified sample to each well. This was done in 3 parallels. The negative control was set to 
50 μL RPMI-1640 with 10 % FBS and 50 μL RPMI-1640 without FBS. The plates were 
incubated for 3 days at 5 % CO2, 37 oC. 
Day 5: 
It was added 10 μL AQOS to each well and incubated for 1 hour at 5 % CO2, 37 oC. After 1 hour 




Table 4: Concentration of purified deoxytubastrine (see results for active compounds from D. aggregate) in MTT assay.  
N= Negative control 




(μg/mL)  Control 
  50 50 50       N N 
  40 40 40       N N 
  30 30 30       N N 
  25 25 25       N N 
  15 15 15          
  10 10 10          
  5 5 5          
                        
 
2.9 Purification of active fractions 
Materials and chemicals: 
Waters 600 Controller     Waters  
Waters 2996 Photodiode Array Detector   Waters  
Waters 2767 Sample Manager    Waters  
Atlantis Prep C-18 (10x250 mm; 10μm)   Waters  
Acetonitrile        Merck  
Milli-Q water       Millipore 
Formic acid       Merck 
Waters 600E Multisolvent delivery System   Waters  
Waters Prep Degasser      Waters  
Waters 2767 Sample Manager, Injector and Collector Waters 
Waters 2996 PDA Detector     Waters 
Waters 3100 MS      Waters 
 
The active fractions were purified by mass in a preparative HPLC-MS system. From the tube 
1000 µL of sample was injected in the HPLC column and fractionated with a flow rate of 6 
mL/minutes and the eluent was collected over a time span of 25 minutes. The gradient used in the 







Table 5: Mobile phase gradient for the purification of active fractions 
Time (min) Flow (mL/min) Mobile phase A % 
w/H2O and 0.1 % 
formic acid 
Mobile phase 
B % w/ACN 
and 0.1 % 
formic acid 
Curve 
0 6 95 5 0 
5 6 95 5 6 
20 6 80 20 6 
21 6 5 95 6 
25 6 5 95 6 
 
Table 6: Conditions of the MS-analysis from the purification of active fractions 
                 Conditions                            ES+ 
                 Capillary (kV)                            3.0 
                 Cone (V)                            35 
                 Source Temperature (oC)                            120 
                 Desolvation Temperature (oC)                            300 
                 Cone Gas Flow (L/Hr)                            5 
                 Desolvation Gas Flow (L/Hr)                            550 
                 Syringe Pump Flow (μL/min)                            5 
 
2.10 LC-MS ESI-QqQ 
Materials: 
Nano Acquity UPLC      Waters  
Quattro Premier XE      Waters 
Acetonitrile        Merck 
 
The purified fraction was dissolved in 50 % Acetonitrile and analyzed by being injected into the 
Tandem MS. The analyses were made in positive mode only. In table 7 the conditions of the MS 
is described closer. 
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Table 7: Conditions of the MS-analyze from active fractions having antiviral effect from D.aggregata. 
                 Conditions                             ES+ 
                 Capillary (kV)                             3.30 
                 Cone (V)                             30.00 
                 Source Temperature (oC)                             100 
                 Desolvation Temperature (oC)                             250 
                 Cone Gas Flow (L/Hr)                             4 
                 Desolvation Gas Flow (L/Hr)                             49 
                 Collision                             18 
                 Syringe Pump Flow (μL/min)                             20.0 
  
2.11 LC-MS ESI-TOF 
Materials: 
LCT  Premier TOF MS     Waters 
2795HT HPLC      Waters  
XTerra® MS C18 (1.0x150 mm; 3.5 µm)       Waters 
Acetonitrile        Merck 
Formic acid        Sigma-Aldrich 
 
The purified fraction with antiviral activity was subjected to HPLC- ESI-TOF. The analyses were 
made in positive mode only. The conditions of the HPLC and MS are listed in table 8 and 9.   
 





Mobile phase A: 
% H20 w/0.1 % 
formic acid 
Mobile phase B: 
% ACN w/0.1 % 
formic acid 
             0          200          95          5 
             9          200          30          70 
            11          200          5          95 
            19          200          5          95 
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Table 9: Conditions of the MS-analysis from active fractions having antiviral effect from D.aggregata. 
                 Conditions                            ES+ 
                 Capillary (kV)                            2.6 
                 Cone (V)                            35 
                 Source Temperature (oC)                            120 
                 Desolvation Temperature (oC)                            300 
                 Cone Gas Flow (L/Hr)                            5 
                 Desolvation Gas Flow (L/Hr)                            550 




Varian Spectrometer 400 Mhz    Varian (Palo Alto, USA) 
Varian VnmrJ-software     Varian 
Deuterated Methanol      Merck 
 
The purified fraction was subjected to Varian 400 NMR spectrometer. The sample was dissolved 







3.1 Metridium senile 
3.1.1 Samples, extracts and fractions 
The weight of the sea anemone Metridium senile (M09036) was 1500 grams and after freeze-
drying the weight of the sample was 152.54 grams. The freeze-dried sample was subjected to 
both an aqueous and an organic extraction. The dry weight of the aqueous extract was 45.37 
grams while the dry weight for the organic extract was 75.41 grams. 
Aliquots of aqueous (213 mg) and the organic (241.5, 258.8 mg) extractions were the basis in 
which the fractionation were made by HPLC. The HPLC fractions were tested for bioactivity as 
described in the Materials and Methods section. 
Subsequent fractions that showed bioactivity were retested in different dilutions to confirm the 
activity. 
Figure 8 shows the UV-chromatogram from the primary fractionation of extracts from M.senile. 
The chromatogram is integrated for wavelength between 200 and 600 nm. As it can be seen, most 
components absorbs in the UV-area in the organic extract. The area where there was most 









Figure 8: UV-chromatogram for the wavelength 200-600 nm of the aqueous (top) and organic fractionation (bottom) of M.senile.  
 
3.1.2 Antiviral screening of M.senile 
3.1.2.1 Organic fractions 
Fraction number 26 (M09036-0-L01) displayed activity as showed in figure 9. The number of 
plaques was considerably less than the virus control. Fraction number 25 and 27 was also picked 
for a second screening even though they had many plaques compared to the virus control. But 
when comparing them with the control, the plaques size was smaller. Based on these 


























































Fractions 25, 26 and 27 were then retested in dilutions of 1:1, 1:2, 1:4to confirm the observations 
from the first screening. For fraction 26 as shown in figure 10, all the dilutions had more plaques 
than the control. The 1:1 dilution for fraction 26 and 27 has no plaques at all, but this activity 
disappeared when diluted further, so none of the fractions underwent further purification. 
 
3.1.2.2 Aqueous fractions 






















Figure 11: Antiviral activity of the 40 aqueous fractions of M.senile.  
 
3.2 Halocynthia pyriformis  
3.2.1 Samples, extracts and fractions 
The weight of the sea anemone Halocynthia pyriformis (M09038) was 954.7 grams and after 
freeze-drying the weight of the sample was 104.6 grams. The freeze-dried sample was subjected 
to both an aqueous and an organic extraction. The dry weight of the aqueous extract was 51.93 
grams while the dry weight of the organic extract was 52.33 grams. 
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Aliquots of the aqueous (211.8 mg) and the organic (288 mg and 293 mg) extractions were the 
basis in which the fractionation was made by HPLC. The HPLC-fractions were tested for 
bioactivity as described in the Materials and Methods section. 
Subsequent fractions that showed bioactivity were retested in different dilutions to confirm the 
activity.  
Figure 12 shows the UV-chromatogram from the primary fractionation of extracts from 
H.pyriformis. The chromatogram is integrated for wavelength between 200 and 600 nm. As it can 
be seen, most components also here absorbs in the UV-area in the organic extract. The area 




Figure 12: UV-chromatogram for the wavelength 200-600 nm of the aqueous and organic fractionation of H.pyriformis. 
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3.2.2 Antiviral screening of H.pyriformis 
3.2.2.1 Organic fractions 
Fractions 25, 28, 29, 30 and 31 (M09038-0-L01) displayed activity in the first screening as seen 
in figure 13. 
Fraction 31 inhibited HSV-1 plaque formation completely, while 25, 28, 29 and 30 had some 
effect. Plaque size was also affected compared to the virus control. It was also decided to retest 
fraction 32, even though it had many plaques, but these showed very small characteristic plaques 
compared to the virus control. There were also observed cytotoxic effect on the Vero cells not 
caused by the virus in fraction 30, 31 and 32.  
 
Figure 13: Antiviral activity of the 40 organic fractions from HPLC of extracts from H.pyriformis. The stars indicating the 
fractions with cytotoxic effects. 
 
Fractions 25, 28, 29, 30, 31 and 32 were retested in dilutions of 1:1, 1:2 and 1:4 to confirm the 
activity as seen in figure 14 and 15.  When diluted the fractions had little activity compared to 


















































Figure 15: Antiviral activity of fraction 30, 31 and 32 when retested 
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3.2.2.2 Aqueous fractions 
The primary fractionation (M09038-0-W01) did not show any clear inhibition of HSV-1 in any 
plaques as seen in figure 16. Fraction number 3 had affected the plaque size compared to the 
























Figure 16: Antiviral activity of the 40 aqueous fractions from HPLC of extracts from H.pyriformis 
 
Fraction 3 was retested in dilutions of 1:1, 1:2 and 1:4 to confirm the activity. Fraction number 3 
did not show any activity in the re-test as seen in figure 17. Also there were no longer any 


























Figure 17: Antiviral activity of fraction 3 when retested 
 
3.3 Parastichopus tremulus 
3.3.1 Samples, extracts and fractions 
The weight of Parasitchopus tremulus (M09037) was 995 grams and after freeze-drying the 
weight of the sample was 87.31 grams. The freeze-dried sample was subjected to both an aqueous 
and an organic extraction. The dry weight of the aqueous extract was 35.55 grams while the dry 
weight for the organic extract was 51.76 grams. 
 
Aliquots of aqueous (209.9 mg) and the organic (297.5 and 295.8) extractions were the basis in 
which the fractionation was made by HPLC. The HPLC-fractions were tested for bioactivity as 
described in the Materials and Methods section. 




Figure 18 shows the UV-chromatogram from the primary fractionation of extracts from 
P.tremulus. The chromatogram is integrated for wavelength between 200 and 600 nm. As it can 
be seen, most components also here absorbs in the UV-area in the organic extract. The area 










3.3.2 Antiviral screening of P.tremulus 
3.3.2.1 Organic fractions 
The primary fraction showed activity against HSV-1 in fractions 15, 16, 24, 25 and 26 (M09037-
0-L01) since they had much less plaques compared to the virus control. Fraction 23, 27 and 28 
were also retested since the plaque size was affected compared to the virus control as seen in 





















Figure 19: Antiviral activity of the 40 organic fractions from HPLC of extracts from P.tremulus 
 
Fractions 15, 16, 23, 24, 25, 26, 27 and 28 were retested in dilutions of 1:1, 1:2, and 1:4 to 
confirm their activity as seen in figure 20, 21 and 22. In the second screening the activity could 

















































































Figure 22: Antiviral activity of fraction 27 and 28 when retested. 
 
3.3.2.2 Aqueous fractions: 
The primary fraction displayed activity against HSV-1 on fractions 35, 36 and 37 (M09037-0-
W01) as seen in figure 23. All the fractions had plaque size that was affected compared to the 
virus control. There was also observed cytotoxic effect on the Vero cells not caused by the virus 
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Figure 24: Antiviral activity of fractions 35, 36 and 37 when retested. 
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Fractions 35, 36 and 37 were retested in dilutions of 1:1, 1:2, and 1:4 to confirm their activity as 
seen in figure 24. In the second screening all the fractions showed no activity, and it was decided 
not to work any further with these fractions.  
 
3.4 Dendrodoa aggregata 
3.4.1 Samples, extracts and fractions 
The weight of Dendrodoa aggregata (M06039) was 312.8 grams and after freeze-drying the 
weight of the sample was 45.68 grams. The freeze-dried sample was subjected to both an aqueous 
and an organic extraction. The dry weight of the aqueous extract was 6.64 grams while the dry 
weight for the organic extract was 3.94 grams. 
Aliquots of the organic (250 mg) extractions were the basis in which the fractionation was made 
by HPLC. The HPLC-fractions were tested for bioactivity as described in the Materials and 
Methods section. 
Figure 25 shows the UV-chromatogram from the primary fractionation of extracts from 
D.aggragata. The chromatogram is integrated for wavelength between 200 and 600 nm. The area 
where there was most absorption also showed activity when the fractions where later screened for 
antiviral activity. 
 
Figure 25: UV-chromatogram for the wavelength 200-600 nm of the organic fractionation of D.aggregata. 
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3.4.2 Antiviral screening of Dendrodoa aggregata 
3.4.2.1 Organic fractions: 
In the primary screening fractions 3 - 8, 12-17 and 29-31 showed small indications of plaques, 
the fractions from 9-11 had all inhibited HSV-1 as seen in figure 23. Previous pilot studies with 
deoxytubastrine had indicated some effect against HSV-1 (data not shown). In the literature it has 
been demonstrated that tubastrine has antiviral activity [17]. Studies of the fractions in figure 26 
showed fraction 3 exerted antiviral activities. LC-MS of fraction 3 shows that deoxytubastrine is 
the dominating compound in fraction 3, and based on this it was decided to purify 




























Figure 27: Pictures of plaques of the PRA from D.aggregata. A: Negative control B: positive control C: plaques from fraction 3.  
 
Figure 27 shows pictures of the plaques from the primary screening of D.aggregata. 
 
Figure 28: LC-MS ESI-TOF BPI ES+ from fraction 3 in D.aggregata. 
 
Figure 28 shows the base peak index in LC-MS ESI-TOF in positive mode of fraction 3 from 
D.aggregata. The first peak of the specter is the base peak with m/z 178.0906.  
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Figure 29: ESI+ MS spectra of the base peak from fraction number 3 D.aggregata. 
 
Based on the base peak index, accurate mass and isotope distribution was made for fraction 3. 
Figure 29 shows LC-MS ESI-TOF specter with positive mode of fraction 3 from D.aggregata. 
The specter revealed one major peak of m/z 178.0906. The elemental composition analysis 
suggested the molecular formula to be C9H11N3O. Searches on Dictionary of Marine Natural 
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Figure 31: ESI+ MSMS daughter scan specter from deoxytubastrine 
 
Figure 31 shows the fragmentation of m/z 177.8 in LC-MS ESI-QqQ in positive mode. 
 
Figure 32: NMR specter of Deoxytubastrine. 
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The purified deoxytubastrine was also subjected to 1H-NMR analysis. Figure 32 shows the 1H-
NMR specter. In the specter, the protons with chemical shift at 6.6 ppm and 7.5 ppm are 
characteristic to the protons on the benzene ring. The protons with chemical shift on 6.5 ppm and 
7.0 are characteristic to the protons on the two carbon atoms on  




The organic extract from before HPLC-fractionation underwent a dose-response test to find out at 
which concentrations the plaques are formed and to check if any concentrations are toxic to the 
Vero cells. As shown in figure 33, the concentrations between 500-100 μg/mL there were no 
plaques at all. These concentrations were also cytotoxic to the Vero cells. There were no cells 
alive at 500 μg/mL, at 250 and 100 μg/mL some cells were alive. At 75 μg/mL there was 
observed some plaques, but the plaque size was affected compared to the virus control. First at 50 
μg/mL there were a significant number of plaques, but also here the plaque size was affected 
compared to the control. 
 
 
Figure 33: Dose respons for  the organic extract. Stars indicate the cytotoxic concentrations. 
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Purified deoxytubastrine was tested for dose-response. The data showed that none of the 
concentrations inhibited plaque formation of HSV-1 as seen in figure 34. The concentrations 
between 50 μg/mL and 15 μg/mL had plaque sizes that were affected compared to the virus 
control.   





















Figure 34: Dose response for purified Deoxytubastrine. 
 
Purified deoxytubastrine was also tested for cytotxicity against Vero cells in the MTT- test. The 
results showed that deoxytubastrine is not cytotxic to Vero cells in the concentrations it was 







































4.1 Antiviral screening 
Since the organic and the aqueous extract are very complex, and can contain several components, 
fractionating them will distribute the compounds in the different fractions based on their chemical 
properties.  
M.senile, H.pyriformis and P.tremulus were subjected to aqueous and organic fractionation. As it 
has been shown in the results most of the activity that were shown appeared in the organic 
fractions. Only one fraction (M09038-0-W01-3) in figure 16 from the aqueous fractions showed 
some activity.  This might be because of the difficulties associated with the isolation and 
purification of water-soluble compounds. The abundance of salt from seawater into the water 
extracts makes the isolation of the compounds more perplexing[18].  
Fraction 3 (M09038-0-W01) might have shown activity in the primary screening because of the 
presence of salts in the fraction. There are generally a lot of inorganic salts like NaCl in marine 
samples. The presence of these salts can influence the activity of the fractions. This can be the 
reason to the loss of the activity when diluted. 
Retesting is made to verify if the activity from the primary fractions are true or false. The retest is 
made by testing the activity in different concentrations, in this way we can find out whether the 
activity is strong enough to be found when the compounds are further purified.  
Retesting the active fractions from the primary screening in different dilutions showed no activity. 
Loss of activity is very common when it comes to retesting. The dilutions of the samples will also 
dilute the concentrations of the active compounds, which could be a possible reason for why the 
activity is lost. Improper calculations of the dilutions can also have an effect on the retested 
results. The PRA itself is a time consuming assay. It is not easily automated, and since the testing 
is done in 24 well plates and not in 96 well plates it means that a bigger volume of media and 
compounds are needed. This can make it more difficult to work with the assay and make room 
for more errors which could have an effect on the activity. Literature search did not yield any 
compounds with antiviral activity in the 3 organisms, so it was decided not to investigate further 




4.2 Analysis  
The MS-QqQ ESI in positive mode gave us several fragmentations of m/z 178.0906 (figure 31). 
The MS-QqQ has a slightly different m/z for deoxytubastrine than MS-TOF, since it is not as 
sensitive as the TOF when it comes to accurate mass. Based on the fragments a list of possible 
elemental compositions was made, as seen in table 10. 
 
Table 10: Possible elemental compositions of m/z 178.0906 calculated based on LC-MS ESI-QqQ specter. 
Daughter ion Possible elemental composition 







The base peak index in LC-MS ESI-TOF in positive mode (figure 28) revealed one major peak of 
m/z 178.0906 after 0.57 minutes. When comparing this specter with the UV-chromatogram from 
the organic fraction of D.aggregata (figure 25) and the figure with the antiviral activity from the 
primary fractions in D.aggregata (figure 26), one can see in all the figures that after 
approximately 3 minutes in the primary fractionation there has been eluted compounds which 
later showed it contained deoxytubastrine. 
    
Drawing the structure of deoxytubastrine (figure 31) in Chemdraw, gave us an estimated specter 
of 1H-NMR of deoxytubastrine that can be seen in figure 36. 
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Figure 36: Estimated specter of deoxytubastrine from Chemdraw. 
 
When we compare the estimated 1H-NMR specter (figure 36) with the 1H-NMR specter (figure 
34) from the sample, we can see similarities between them suggesting they are the same 
compounds. Table 11 compares the chemical shifts from the estimated 1H-NMR specter and the 








Table 11: Comparison of the estimated chemical shifts and the actual chemical shifts of the protons bonded to C-atoms of 
deoxytubastrine. 
Estimated 1H-NMR  1H-NMR from deoxytubastrine 
                  6.51 ppm                      6.5 ppm 
                  6.90 ppm                      7.0 ppm 
                  7.56 ppm                      7.5 ppm 
                  7.56 ppm                      7.5 ppm 
                  6.65 ppm                      6.6 ppm 





















Since tubastrine has shown antiviral activity earlier[17] it was decided to purify deoxytubastrine 
for further studies. The difference between tubasterine and deoxytubastrine are the loss of an OH-
group in meta position in deoxytubastrine. When running dose-response on the extract (M06039-
0-L01), the results showed clearly inhibition on HSV-1. But after the purification the dose-
response test on deoxytubastrine showed no antiviral effect at all. The reason for this might be 
that deoxytubastrine alone does not have any antiviral effect, but might have synergetic effects 
with other compounds in fraction number 3, which gives it the antiviral effect. This synergetic 
effect might have been lost when deoxytubastrine was purified, and because of that the antiviral 
activity was no longer displayed.  
 Another reason for the lack of activity might be that we have purified the wrong compound in 
fraction 3, meaning that there actually is some other compounds in the fraction that has the 
antiviral activity. One possibility is to go back to fraction 3 and try to purify on other compounds 
to see if they have any antiviral activity. 
Many different factors can influence the production of secondary metabolites from marine 
organisms. Geographical and environmental factors and seasonal variation could play an 
important role in producing secondary metabolites with pharmacological effects. 
Since tubastrine has shown anti viral activity and deoxytubastrine did not, a theory could be 
whether it actually is the lost OH-group in deoxytubastrine that causes the antiviral activity. To 














Table 12 : Conditions of the LC-MS ESI-Q 
                   Conditions                            ES + 
                   Extractor (V)                            4.00 
                   RF Lens (V)                            0.3 
                   LM 1 Resolution                            15.0 
                   HM 1 Resolution                            15.0 
                   Ion Energy 1                            1.0 
                   Entrance                            0 
                   Exit                            0 
                   LM 2 Resolution                                 14.5 
                   HM 2 Resolution                            14.5 
                   Ion Energy 2                            1.0 
                   Multiplier                            600 
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